Vyne Therapeutics Inc (VYNE)
1.4000 x 50 1.6900 x 1
Post-market by (Cboe BZX)
1.5550 +0.0750 (+5.07%) 04/11/25 [NASDAQ]
1.4000 x 50 1.6900 x 1
Post-market 1.5550 unch (unch) 16:00 ET
for Fri, Apr 11th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -39,834 | -28,452 | -23,210 | -73,329 | -255,568 |
| Depreciation Amortization | -2,439 | -255 | 72 | 109 | 54,686 |
| Accounts receivable | -899 | 405 | 11,210 | N/A | -17,138 |
| Other Working Capital | 4,999 | 60 | 2,277 | 4,776 | -40,331 |
| Other Operating Activity | 4,201 | 2,901 | -19,549 | 12,077 | 121,269 |
| Operating Cash Flow | $-33,972 | $-25,341 | $-29,200 | $-56,367 | $-137,082 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 23,482 | -62,354 | N/A | N/A | N/A |
| PPE Investments | -117 | N/A | N/A | N/A | -113 |
| Net Acquisitions | N/A | 5,000 | 15,667 | N/A | 38,641 |
| Sale Of Investment | N/A | N/A | N/A | 1,027 | 50,579 |
| Investing Cash Flow | $23,365 | $-57,354 | $15,667 | $1,027 | $89,107 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -36,432 | N/A |
| Common Stock Issued | N/A | 82,821 | 1,470 | 76,503 | 61,949 |
| Other Financing Activity | -141 | -427 | 183 | -294 | -141 |
| Financing Cash Flow | $-141 | $82,394 | $1,653 | $39,777 | $61,808 |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | 1 |
| Beginning Cash Position | 30,674 | 30,975 | 42,855 | 58,418 | 44,584 |
| End Cash Position | 19,926 | 30,674 | 30,975 | 42,855 | 58,418 |
| Net Cash Flow | $-10,748 | $-301 | $-11,880 | $-15,563 | $13,834 |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,972 | -25,341 | -29,200 | -56,367 | -137,082 |
| Capital Expenditure | -117 | N/A | N/A | N/A | -113 |
| Free Cash Flow | -34,089 | -25,341 | -29,200 | -56,367 | -137,195 |